13-May-2024
Olink drops after UK antitrust regulator starts review of Thermo Fisher deal
Seeking Alpha News (Fri, 10-May 10:02 AM ET)
Thermo Fisher Scientific to Present at BofA Securities 2024 Health Care Conference on May 14
Business Wire (Tue, 7-May 8:00 AM ET)
Business Wire (Wed, 1-May 8:00 AM ET)
Thermo Fisher Scientific to Host Investor Day
Business Wire (Wed, 24-Apr 6:05 AM ET)
Thermo Fisher Scientific Reports First Quarter 2024 Results
Business Wire (Wed, 24-Apr 6:00 AM ET)
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, April 24, 2024
Business Wire (Tue, 2-Apr 8:00 AM ET)
Thermo Fisher Scientific to Present at TD Cowen 44th Annual Health Care Conference on March 6, 2024
Business Wire (Wed, 28-Feb 8:00 AM ET)
Thermo Fisher Scientific Increases Quarterly Dividend
Business Wire (Wed, 21-Feb 5:00 PM ET)
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of end-2023 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (10%); life science solutions (23%); and lab products and services, which includes CRO services (54%).
Thermo Fisher Scientific trades on the NYSE stock market under the symbol TMO.
As of May 13, 2024, TMO stock price declined to $590.70 with 819,933 million shares trading.
TMO has a beta of 1.24, meaning it tends to be more sensitive to market movements. TMO has a correlation of 0.51 to the broad based SPY ETF.
TMO has a market cap of $225.24 billion. This is considered a Mega Cap stock.
Last quarter Thermo Fisher Scientific reported $10 billion in Revenue and $5.11 earnings per share. This beat revenue expectation by $175 million and exceeded earnings estimates by $.40.
In the last 3 years, TMO stock traded as high as $672.34 and as low as $415.60.
The top ETF exchange traded funds that TMO belongs to (by Net Assets): VTI, VOO, SPY, IVV, XLV.
TMO stock has underperformed the market in the last year with a return of +12.9%, while SPY returned +28.2%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in TMO shares. However, TMO has outperformed the market in the last 3 month and 2 week periods, returning +9.7% and +2.4%, while SPY returned +5.8% and +2.1%, respectively. This indicates TMO has been having a stronger performance recently.
TMO support price is $585.16 and resistance is $600.90 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TMO stock will trade within this expected range on the day.